Fig 1.
PRISMA flow diagram for the systematic review conducted between 1996 to August 2024.
Table 1.
Effect of glycemic control (stringent or less stringent) on unfavorable TB treatment outcomes, summarized as crude/adjusted relative risk/ odds ratio (cRR/ aRR/ cOR/ aOR) @*.
Table 2.
Effect of glucose lowering treatment on unfavorable TB treatment outcomes, summarized as crude and adjusted relative risk (cRR/ aRR)@*.
Table 3.
Summary of risk of bias in included studies assessed using Modified New Castle Ottawa quality assessment scale for cohort studies @.
Table 4.
Ten measures* for robustly designed and analyzed cohort studies on the effect of glycemic control and/or type of DM treatment on TB treatment outcomes among people with TB-DM [20].